Clinical Trials Sponsored by National Institute of Respiratory Diseases, Mexico

Total 6805 results

National Institute of Allergy and Infectious Diseases...

Terminated

Improving Transplant Options of Highly Sensitized Recipients Using IGIV-C, 10%

Kidney Failure, Chronic

United States
National Institute of Allergy and Infectious Diseases...

Completed

An Evaluation of IV Gamma Globulin As a Method to Improve Kidney Transplant Survival in Patients With End-Stage Renal Disease Who Are Highly Sensitized to Transplant Antigens

Kidney Transplantation | End-Stage Renal Disease

United States
National Institute of Allergy and Infectious Diseases...

Completed

ZOSTAVAX® in Renal Transplant Patients

Herpes Zoster

United States
National Institute of Allergy and Infectious Diseases...

Completed

Chloroquine for Malaria in Pregnancy

Malaria

Malawi
National Institute of Allergy and Infectious Diseases...

Completed

Therapeutic HIV Vaccine and Interleukin-2 to Increase the Immune System's Response to HIV

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Evaluation of the Safety and Immunogenicity of rDEN3Δ30, a Live Attenuated Monovalent Dengue Virus Vaccine

Dengue

United States
National Institute of Allergy and Infectious Diseases...

Completed

Heterosexual HIV Transmission Study (HATS)

HIV Infections | Healthy

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety, Tolerability and PK 3-Period Crossover Study Comparing 2 Single Doses of ZTI-01 and Monurol® in Healthy Subjects

Pseudomonas Infection

United States
National Institute of Allergy and Infectious Diseases...

Completed

Linezolid to Treat Extensively-Drug Resistant Tuberculosis

Pulmonary Tuberculosis | Multidrug Resistant Tuberculosis | Extensively Drug Resistant Tuberculosis

Korea, Republic of
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety and Immune Response to an H5N1 Influenza Vaccine in People Who Have Previously Received an H5N1 or H7N3 Influenza Vaccine and in People Who Have Never Received a Live Attenuated Influenza Vaccine

H5N1 Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru (HVTN 914)

HIV Infections | Acquired Immunodeficiency Syndrome | RNA Virus Infections | Virus Diseases | Sexually Transmitted Diseases, Viral | Sexually Transmitted Diseases | Lentivirus Infections | Retroviridae Infections | Immunologic Deficiency Syndromes | Immune System Diseases | Slow Virus Diseases
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety and Immune Response to a Dengue Virus Vaccine in Healthy Adults

Dengue

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Study to Monitor Patients With Primary or Early HIV Infection

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety and Immune Response to a Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children

Respiratory Syncytial Virus Infections

United States
National Institute of Liver & GI Diseases, Pakistan
Abbott

Unknown

UBT as a Diagnostic Tool for HP Prevalance

Dyspepsia

Pakistan
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine

Dengue

United States
National Institute of Allergy and Infectious Diseases...

Withdrawn

High Dose Influenza in Immunosuppressed Subjects

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Withdrawn

A Study to See if Certain Antioxidants and Vitamins Will Keep Lactate Levels Down in Patients Taking Anti-HIV Drugs

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Terminated

Hormone Replacement Therapy and Anti-HIV Drugs in HIV-Infected, Postmenopausal Women

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Withdrawn

Salvage Treatment, Resistance Testing, and Withdrawal of Anti-HIV Drugs for HIV Patients Failing Current Anti-HIV Treatment

HIV Infections

United States, Puerto Rico
National Institute of Allergy and Infectious Diseases...

Completed

Genomics of Chronic Renal Allograft Rejection (The GoCAR Study)

Kidney Transplantation

United States, Australia
National Institute of Allergy and Infectious Diseases...

Withdrawn

A Study of Patients Who Recently Have Been Infected With HIV

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Increasing HAART-Induced Immune Restoration With Cyclosporine

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Post-Partum Immunization With Live Attenuated Influenza Vaccine (LAIV) or Trivalent Influenza Vaccine (TIV) in Post-Partum Breast Feeding Women

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

TIV and High Dose TIV in Subjects With Rheumatoid Arthritis

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

2010-2011 Trivalent Influenza Vaccine (TIV) in Pregnant Women

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

Eldery High Dose TIV 2005

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

Combination Study With MVA BN and Dryvax

Smallpox

United States
National Institute of Allergy and Infectious Diseases...

Terminated

Caspofungin Study for Fungal Infections in Adults in Critical Care Settings

Candidiasis

United States
National Institute of Allergy and Infectious Diseases...

Completed

FLU-VACS Comparative Study in Adults

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

9-valent CRM 197 Pneumococcal

Pneumococcal Infection

United States
National Institute of Allergy and Infectious Diseases...

Completed

When to Start Anti-HIV Drugs in Patients With Opportunistic Infections

HIV Infections | AIDS-Related Opportunistic Infections

United States, Puerto Rico, South Africa
National Institute of Allergy and Infectious Diseases...

Withdrawn

Safety and Efficacy of Oseltamivir in Children Younger Than One Year of Age

Influenza
National Institute of Allergy and Infectious Diseases...

Completed

Leprosy Skin Test Antigens Phase 1

Leprosy
National Institute of Allergy and Infectious Diseases...

Completed

Adenovirus Type 35 Based Circumsporozoite Malaria Vaccine in Burkina Faso

Malaria

Burkina Faso
National Institute of Allergy and Infectious Diseases...

Completed

Assessment of the Immunogenicity and Safety of a Dose-Sparing BioThrax® AVA Schedule

Bacillus Anthracis (Anthrax)

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Study of Anal Cancer Development in HIV Infected People

HIV Infections | Anus Neoplasms

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Study to Evaluate the Long-Term Effectiveness of Three Anti-HIV Drug Regimens in HIV Infected Patients Who Have Never Been Exposed to Highly Active Antiretroviral Therapy (HAART)

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

The Effect of Anti-HIV Therapy on Fat Metabolism in HIV-Positive Patients

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Effects of Anti-HIV Therapy on Nervous System Function

HIV Infections

United States, Brazil, Australia, Thailand, Canada
National Institute of Allergy and Infectious Diseases...

Completed

A Study of the Long-Term Outcomes of HIV-Positive Patients

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Identifying Genetic Determinants of Eczema Herpeticum and Other Viral Infections in Individuals With Atopic Dermatitis (Genetics)

Atopic Dermatitis

United States
National Institute of Allergy and Infectious Diseases...

Completed

Initial Study of Malaria Vaccine Pfs25-EPA/Alhydrogel(Registered Trademark)

Malaria

United States
National Institute of Allergy and Infectious Diseases...

Terminated

Detoxified J5 Core Glycolipid/ Group B Meningococcal Outer Membrane Protein Vaccine for Gram-negative Bacterial Sepsis Administered With and Without Synthetic CPG Oligodeoxynucleotide 7909 Adjuvant

Bacterial Sepsis

United States
National Institute of Allergy and Infectious Diseases...

Completed

Clinical IGSP-CHOP Boston

Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

Studies of Influenza Vaccine and Tetanus-Pneumococcal Vaccine in HIV-infected Patients Receiving Interleukin-2

HIV Infections

United States, Denmark
National Institute of Allergy and Infectious Diseases...

Completed

HIV in Specific Parts of the Body of Patients Who Are Changing or Starting Potent Anti-HIV Drugs

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Comparison of Two Anti-HIV Treatment Plans

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV Infection

HIV Infections

Canada
National Institute of Allergy and Infectious Diseases...

Completed

H5N1 Priming and Boosting Strategies

Influenza

United States

Clinical Trials Sponsored by National Institute of Respiratory Diseases, Mexico

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Netherlands

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations